• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Economy

    Trump touts ‘Made in America’

    Josh Siegel -
    July 21, 2017 10:40 pm
    0
    Heather Bresch, chief executive officer of Mylan NV, holds up Mylan EpiPen medication during a House Oversight and Government Reform Committee hearing on Sept. 21, 2016. Lawmakers questioned Bresch about why the company raised the price of the life-saving injection to $600 for a two-pack, from $57 a shot when it took over sales of the product in 2007. (Andrew Harrer/Bloomberg)
    Healthcare

    Maryland ‘price gouging’ law meets immediate legal challenge

    Kimberly Leonard -
    July 17, 2017 4:01 am
    0
    The problem here is very clear: How can public policy lower the price of prescription drugs? The answer, however, differs greatly depending on who you ask. (iStock photo)
    Beltway Confidential

    Letting the government ‘negotiate’ with drug companies is just window dressing for price controls

    Brandon Arnold -
    July 13, 2017 4:22 pm
    0
    Lawmakers passed a bill that would let the FDA continue to collect user fees from drug and device makers, with the agency using that revenue to speed up approval of new products. (AP Photo/Andrew Harnik)
    Healthcare

    House advances FDA funding bill

    Robert King -
    July 12, 2017 6:40 pm
    0
    Republicans are working to speed up approval of generic drugs in particular to offer more competition and lower prices.
    Healthcare

    Democrats disappointed Trump hasn’t worked to lower drug prices

    Robert King -
    June 26, 2017 4:01 am
    0
    It's no surprise that marketing works. (AP Photo/Sue Ogrocki, File)
    Op-Eds

    Are Big Pharma gifts to physicians an expensive problem, or a red herring?

    Brian Joondeph -
    June 23, 2017 12:00 pm
    0
    Rep. Elijah Cummings, D-Md., and Rep. Peter Welch, D-Vt., who met with President Trump earlier this year over tackling drug prices, are dismayed at the lack of action from the White House. (AP Photo/Pablo Martinez Monsivais)
    Healthcare

    House Democrats slam Trump ‘betrayal’ on drug prices

    Robert King -
    June 21, 2017 3:00 pm
    0
    This is the first time the FDA has taken steps to take a prescription painkiller off the market because of its risk for addiction. (AP Photo/Chris Post)
    Healthcare

    An FDA first: Agency asks drug company to take its opioid off the market

    Kimberly Leonard -
    June 8, 2017 9:34 pm
    0
    One of the moves Congress and the FDA are looking at is a loophole that major pharmaceutical companies use to stop generic makers from creating a cheaper copy.
    Healthcare

    FDA takes bigger role in lowering drug prices

    Robert King -
    June 5, 2017 4:01 am
    0
    The pharmaceutical giant has raised prices an average of 20 percent this year. (AP Photo/Richard Drew, File)
    Healthcare

    Pfizer hikes price on nearly 100 drugs, report says

    Robert King -
    June 2, 2017 7:57 pm
    0
    1...111112113...159Page 112 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.